Consequently, adiponectin deficiency has been linked to an increased risk of metabolic syndrome components, including obesity, type 2 diabetes mellitus, hypertension, and cardiovascular diseases [40,43,44]. Here, ADIPOQ is linked to metabolic syndrome.